1. Effects of quinolones on tumor necrosis factor production by human monocytes
- Author
-
Marie-Anne Gougerot-Pocidalo, Michèle Fay, Y. Roche, and Sabine Bailly
- Subjects
medicine.medical_treatment ,Immunology ,Biology ,Pharmacology ,In Vitro Techniques ,Quinolones ,Monocytes ,Tumor necrosis factor production ,1-Methyl-3-isobutylxanthine ,medicine ,Extracellular ,Cyclic AMP ,Humans ,Antibacterial agent ,Tumor Necrosis Factor-alpha ,Monocyte ,Interleukin ,Monokine ,Kinetics ,Cytokine ,medicine.anatomical_structure ,Tumor necrosis factor alpha ,Extracellular Space ,Interleukin-1 - Abstract
Previous studies have shown that in lipopolysaccharide (LPS)-stimulated human monocytes, interleukin 1 (IL-1) production is altered by quinoline derivative antibiotics (quinolones), in a way which depends both on the dose and on the agents used. Given that Il-1 and tumor necrosis factor alpha (TNF) are produced in response to LPS and have some overlapping and synergistic activities, we sought to determine if TNF production was altered under the above-mentioned conditions. We investigated the effects of three quinolones: ciprofloxacin (Cip), pefloxacin (Pef) and ofloxacin (Ofl). These quinolones were found to decrease extracellular TNF production in a dose-dependent manner at concentrations higher than 25 μg/ml as previously described by our laboratory with regard to IL-1 production. Moreover, the order of the extracellular decrease in TNF and IL-1 induced by each drug was similar. However, in contrast to IL-1 activity, the quinolones studied also reduced cell-associated TNF. The kinetics of TNF production suggested that the quinolones affected TNF production at a very early step, probably during TNF synthesis rather than during its secretion into the extracellular medium. Furthermore, the quinolone-induced accumulation of intracellular cAMP could explain the extracellular decrease in both IL-1 and TNF production.
- Published
- 1990